Ebola containment efforts in Congo prove effective, health officials say

Health officials overseeing the Ebola outbreak in the Democratic Republic of the Congo said efforts to halt the disease from spreading are proving successful, according to STAT’s Morning Rounds e-newsletter released Sept. 20.

Advertisement

More than 10,000 doses of Merck’s experimental Ebola vaccine have been administered in the Congo, Dr. Peter Salama, medical epidemiologist at the World Health Organization, tweeted Sept. 18.

However, health officials still face major obstacles in containing the outbreak. Healthcare workers tasked with assessing the health of Ebola contacts reported losing track of some, according to STAT. A small portion of Ebola patients have also Ebola refused treatment or fled to highly populated areas.

So far, there have been 142 reported Ebola cases in the Congo, resulting in 97 deaths.

More articles on clinical leadership and infection control:

For-profit hospitals readmit more patients, study finds

Scientists create cooling system for outbreak responders’ protective suits

71% of VA hospitals improved overall quality, agency finds

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

When nurses help build the AI, adoption follows: Lessons from 3 health systems

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Amy McCarthy, DNP, RNC-MNN, NE-BC, CENP, Hippocratic AIBeth Reimschissel, PhD, RN, CNL, Memorial HermannAllison Schlinkert, MSN, RN, NPD-BC, Cincinnati Children'sScott Estep, MBOE, BSN, RN, CSSBB, OhioHealth System

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.